IBAI.LSE Imaging Biometrics Ltd.

Healthcare Health Information Services London Exchange
0.0078 GBX
Close of Nov 3, 2026
0.4000 1.45
Market cap
GBX 1.92M
P/E
-
P/B
4.07x
ROE
96.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is IBAI.LSE undervalued?

Graham number

The Graham number of Imaging Biometrics Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Imaging Biometrics Ltd. fundamental analysis

No fundamental analysis for Imaging Biometrics Ltd. yet.

Imaging Biometrics Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Imaging Biometrics Ltd.

Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro, an MRI perfusion platform that generates quantitative relative cerebral blood v…

Full company profile